Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q2 2026 › vs Q2 2025
Cardio Diagnostics Holdings (CDIO) Q2 2026 vs Q2 2025 (year over year)
Cardio Diagnostics Holdings's revenue fell $2K (-28%) from $7K in Q2 2025 to $5K in Q2 2026.
Cardio Diagnostics Holdings, Q2 2026: revenue $5K (-28% year over year), net loss $1.5M, operating cash flow −$1.3M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $5K | $7K | −$2K | -28% |
| Net loss | $1.5M | $1.7M | −$182K | -11% |
| Costs & expenses | $1.5M | $1.7M | −$184K | -11% |
| Operating costs | $1.5M | $1.7M | −$183K | -11% |
| Interest & other, net | $3K | $4K | −$1K | -26% |
| Operating cash sources | $1.5M | $1.7M | −$182K | -11% |
| Depreciation & amortization | $6K | $8K | −$3K | -34% |
| Share-based compensation | $24K | $31K | −$6K | -21% |
| Working capital & other | $129K | $72K | $57K | +78% |
| Cash used in operations | $1.3M | $1.6M | −$229K | -15% |
| Net loss absorbed | $1.5M | $1.7M | −$182K | -11% |
Questions
How much did Cardio Diagnostics Holdings's revenue grow year over year in Q2 2026?
Cardio Diagnostics Holdings's revenue fell $2K (-28%) from $7K in Q2 2025 to $5K in Q2 2026.